Victory Capital Management »

Biomarin Pharmaceutical shares owned by Victory Capital Management

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Victory Capital Management from 13F filings

Historical chart of Victory Capital Management investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Victory Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Victory Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $14M 14M 1.03
2023-09-30 $19M 19M 0.99
2023-06-30 $13M 13M 1.01
2023-03-31 $7.1M 6.8M 1.04

More positions owned by Victory Capital Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Victory Portfolios Ii Etf (UITB)
Facebook Inc cl a (META)
Alphabet Inc Class C cs (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Ross Stores (ROST)
Alphabet Inc Class A cs (GOOGL)
Leidos Holdings (LDOS)
JPMorgan Chase & Co. (JPM)
Textron (TXT)
Xcel Energy (XEL)

View all positions for Victory Capital Management

Top funds holding Biomarin Pharmaceutical

MacKay Shields
Lazard Asset Management
Wellesley Investment Advisors
iA Global Asset Management
Victory Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management
Bank of America Corporation
Jpmorgan Chase & Co
Wellington Management Company
Amundi
New York State Common Retirement Fund
Bnp Paribas Investment Partners
SSI Investment Management
La Banque Postale Asset Management SA

View all funds holding Biomarin Pharmaceutical